Azenta to sell B Medical Systems unit for $63 million
Share
Azenta (NASDAQ:AZTA) has signed a binding agreement to sell its B Medical Systems business to THELEMA S.À R.L. for $63 million, as the company moves to streamline operations and focus on its core capabilities.
The company said the transaction is expected to close on or before March 31, 2026, subject to customary closing conditions.
Azenta said the divestiture is intended to simplify its portfolio and allow management to prioritize areas aligned with its long-term strategy.
Proceeds from the sale will be used to strengthen the balance sheet and support initiatives aimed at creating long-term value for shareholders.
William Blair served as exclusive financial advisor to Azenta on the transaction, while Taylor Wessing acted as legal counsel.
More from United States
AbbVie revenue increases 10.3% to $17.4 billion in third quarter
Sensient Q3 revenue rockets 10.6% to $455.8 million
Cameco Q3 adjusted loss reaches CA$2 million as uranium output falls
Kite Realty Q3 loss narrows to $13.3 million as NOI grows
Largo cuts 2026 vanadium production outlook to 9,500–10,500 tonnes
nVent Q3 sales jump 44% as shares fall despite higher revenue
